study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MENT-GEN-0229_01,2013,randomized controlled trial,SMD,-0.3296,-0.4565,-0.2027,79,59,low,10.1234/n-acetyl-cysteine-ment-gen-0229-01,mental_health_journal,emotional_wellbeing,Adults with emotional wellbeing concerns,Transient headache,9
MENT-GEN-0229_02,2014,randomized controlled trial,SMD,-0.3327,-0.4743,-0.1911,65,70,some concerns,10.1234/n-acetyl-cysteine-ment-gen-0229-02,mental_health_journal,emotional_wellbeing,Adults with emotional wellbeing concerns,Transient headache,8
MENT-GEN-0229_03,2015,randomized controlled trial,SMD,-0.2848,-0.453,-0.1166,65,58,some concerns,10.1234/n-acetyl-cysteine-ment-gen-0229-03,mental_health_journal,emotional_wellbeing,Adults with emotional wellbeing concerns,Transient headache,11
